Literature DB >> 17322218

The cheaper drug, bevacizumab, should be referred to NICE.

James P Raftery, Andrew Lotery.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17322218      PMCID： PMC1804136          DOI： 10.1136/bmj.39128.708565.3A

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  1 in total

1.  New treatments for neovascular acute macular degeneration.

Authors:  Usha Chakravarthy; Jennifer I Lim
Journal:  BMJ       Date:  2007-02-10
  1 in total
  2 in total

1.  Association between the SERPING1 gene and age-related macular degeneration: a two-stage case-control study.

Authors:  Sarah Ennis; Catherine Jomary; Robert Mullins; Angela Cree; Xiaoli Chen; Alex Macleod; Stephen Jones; Andrew Collins; Edwin Stone; Andrew Lotery
Journal:  Lancet       Date:  2008-10-06       Impact factor: 79.321

Review 2.  Off-label use of bevacizumab for the treatment of age-related macular degeneration: what is the evidence?

Authors:  Focke Ziemssen; Salvatore Grisanti; Karl Ulrich Bartz-Schmidt; Martin S Spitzer
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.